Pharma & Healthcare
Neutrophil Elastase Inhibitator
- Types
- Dociparstat Sodium · POL-6014 · KRP-109
- Applications
- Bronchiectasis · Acute Myelocytic Leukemia · Respiratory
5 editions19 December 2025
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Neutrophil Elastase InhibitatorCompare research options for Neutrophil Elastase Inhibitator